Abstract
The authors report 11 patients with cerebral glioblastoma who lived at least 5 years after their initial diagnosis. There were 6 female and 5 male; the mean age was 39 years (range 24–55 years). All patients were treated surgically and postoperatively received whole-brain radiotherapy and chemotherapy. Five patients (45%) presented local recurrences after an average interval of 3.9 years from treatment. At average follow-up of 9 years (range 5–14 years), 7 patients (64%) were alive after an average interval of 8.1 years; 4 patients (36%) died from local relapse. Survival was influenced by patient age and, to a lesser degree, by treatment. A review of the literature, together with our own series, suggest that death from recurrence disease is unusual in glioblastoma patients who survive more than 5 years.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burger PC, Vogel FS, Green SB, Strike TA: Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 56: 1106–1111, 1985
Mork S, Laerum O, de Ridder L: Invasiveness of tumours of the central nervous system. In: Mareel M, Calman K (eds) Invasion. Experimental and Clinical Implications, Medical Oxford Publications, Oxford 79–125, 1984
Chandler KL, Prados MD, Malec M, Wilson CB: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32: 716–720, 1993
Hollerhage HG, Zumkeller M, Becker M, Dietz H: Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme. Acta Neurochir 113: 31–37, 1991
Jelsma R, Bucy PC: The treatment of glioblastoma multiforme of the brain. J Neurosurg 27: 388–400, 1967
Roth JG, Elvidge AR: Glioblastoma multiforme: a clinical survey. J Neurosurg 17: 736–750, 1960
Takeuchi K, Hoshino K: Statistical analysis of factors affecting survival after glioblastoma multiforme. Acta Neurochir 37: 56–73, 1977
Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16: 1405–1409, 1989
Elvidge AR, Barone BM: Long-term postoperative survival in two cases of glioblastoma multiforme. J Neurosurg 22: 382–386, 1965
Lieberman AN, Foo SH, Ransohoff J, Wise A, George A, Gordon W, Walker R: Long-term survival among patients with malignant brain tumors. Neurosurgery 10: 450–453, 1982
Netsky MG, August B, Fowler W: The longevity of patients with glioblastoma multiforme. J Neurosurg 7: 261–269, 1950
Rutz HP, de Tribolet N, Calmes JM, Chapuis G: Long-time survival of a patient with glioblastoma and Turcot's syndrome: case report. J Neurosurg 74: 813–815, 1991
Salcman M, Scholtz H, Kaplan RS, Kulik S: Long-term survival in patients with malignant astrocytoma. Neurosurgery 34: 213–220, 1994
Salford LG, Brun A, Nirfalk S: Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J Neurosurg 69: 506–509, 1988
Vertosick FT, Selker RG: Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis. Surg Neurol 38: 359–363, 1992
Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumors. Brain Pathol 3: 255–268, 1993
Artico M, Cervoni L, Celli P, Salvati M, Palma L: Supratentorial glioblastoma in children: a series of 27 surgically treated cases. Child's Nerv Syst 9: 7–9, 1992
Salmon I, Kiss R, Dewitte O, Gras T, Pasteels JL, Brotchi J, Flament-Durand J: Histopathologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients. Cancer 70: 538–546, 1992
von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN: Subsets of glioblastoma multiforms defined by molecular genetic analysis. Brain Pathol 3: 19–26, 1993
Walker MD, Green SB, Byar DP, Alexander A Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323–1329, 1980
Iacoangeli M, Roselli R, Prezioso A, Scerrati M, Rossi GF: Staging of supratentorial hemispheric glioma using tumour extension, histopathological grade and extent of surgical resection. Br J Surg 80: 1130–1133, 1993
Duffner PK, Cohen ME: Long-term consequences of CNS treatment for childhood cancer. Part II: clinical consequences. Pediatr Neurol 7: 237–242, 1991
Imperato JP, Paleologos NA, Vick NA: Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 28: 818–822, 1990
Karnofsky DA, Burchenal JM, Armstead GC Jr, Southam SM, Berstein JL, Craver LF, Rhoads CP: Triethylenemelamine in the treatment of neoplastic disease. Arch Int Med 87: 477–516, 1951
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salvati, M., Cervoni, L., Artico, M. et al. Long-term survival in patients with supratentorial glioblastoma. J Neurooncol 36, 61–64 (1998). https://doi.org/10.1023/A:1017926603341
Issue Date:
DOI: https://doi.org/10.1023/A:1017926603341